Showing results (21-30 of 270) with videos related to
Sort By:
Pageof 27
Acta Ophthalmologica|August 23, 2007
Peribulbar poloxamer for ocular drug deliveryKatja Vehanen, Margit Hornof, Arto Urtti, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 25, 2004
Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical propertiesAnnika Mälkiä, Lasse Murtomäki, Arto Urtti, et al.Pharmaceutical Research|May 13, 2003
Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymersLeena Pitkänen, Marika Ruponen, Jenni Nieminen, et al.The Journal of Gene Medicine|April 14, 2004
Cell-surface glycosaminoglycans inhibit cation-mediated gene transferMarika Ruponen, Paavo Honkakoski, Markku Tammi, et al.Molecular Pharmaceutics|January 29, 2016
Interpretation of Ocular Melanin Drug Binding Assays. Alternatives to the Model of Multiple Classes of Independent SitesJosé A Manzanares, Anna-Kaisa Rimpelä, Arto UrttiPharmaceutical Research|July 20, 2016
General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage FormsFeng Deng, Veli-Pekka Ranta, Heidi Kidron, et al.Journal of Chromatography. A|December 5, 2002
Liquid chromatographic-electrospray ionization mass spectrometric analysis of neutral and charged polyethylene glycolsJoni J Palmgrén, Elisa Toropainen, Seppo Auriola, et al.Investigative Ophthalmology & Visual Science|January 27, 2005
Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicityLeena Pitkänen, Veli-Pekka Ranta, Hanna Moilanen, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 4, 2018
Melanin targeting for intracellular drug delivery: Quantification of bound and free drug in retinal pigment epithelial cellsAnna-Kaisa Rimpelä, Marja Hagström, Heidi Kidron, et al.Molecular Pharmaceutics|November 1, 2019
Establishment of an In Vitro-In Vivo Correlation for Melanin Binding and the Extension of the Ocular Half-Life of Small-Molecule DrugsPaulina Jakubiak, Carina Cantrill, Arto Urtti, et al.Pageof 27